FDA issues complete response letter for XARELTO
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 22 Jun, 2012
Singapore: US Food and Drug Administration (FDA) have issued a complete response letter regarding a supplemental New Dru...Read more
Sanofi to develop novel drugs for drug-resistant TB
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2012
Singapore: Sanofi and the Global Alliance for TB Drug Development (TB Alliance) entered a research collaboration to acce...Read more
Lupin aims high with a strong R&D focus
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2012
Lupin Pharmaceutical, which aims to be the best transnational pharmaceutical company in the world, stroked 10.64 percent...Read more
Phosphagenics appoints three new non-executive directors
Drug Discovery | Influencers | By BioSpectrum Bureau | 3 Comment | 04 Mar, 2014
Singapore: Australian drug delivery technology company Phosphagenics has appointed biotech industry veterans Mr Lawrence...Read more
MerLion completes phase I of finafloxacin study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
Singapore: Following successful first-in-man phase I and two phase IIa clinical studies with the oral formulation of fin...Read more
Changing the paradigm of drug development
Drug Discovery | Opinion | By BioSpectrum Bureau | 2 Comment | 08 Feb, 2013
Recent promising data on drug approvals in 2011 shows that there were 35 new molecular entities (NME) approved by the FD...Read more
Medivir, Daewoong end hepatitis drug development
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2013
Singapore: Sweden-based Medivir has discontinued the development of its hepatitis B compound MIV-210 based on a joint de...Read more
Eisai reveals phase III results of breast cancer drug Halaven
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2012
Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...Read more
Antidepressant can treat sickle cell disease
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2013
Singapore: A study by researchers at the University of Michigan Medical School, US, found that antidepressant drug trany...Read more
Pharmaxis to launch cystic fibrosis drug in Europe
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Singapore: Australian pharmaceutical company Pharmaxis is all set to launch Bronchitol for cystic fibrosis (CF) patients...Read more
UK firm withdraws insulin marketing applications
Drug Discovery | Regulatory | By BioSpectrum Bureau | 1 Comment | 28 Nov, 2012
Singapore: UK's Marvel LifeScience, insulin marketing company, has withdrawn its application for centralized marketing a...Read more
Alchemia enrolls patients for cancer trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Mar, 2013
Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead prod...Read more
Bayer, 5 cancer institutes set up oncology network
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2013
Sinapore: Bayer HealthCare in Singapore in collaboration with five research institutions have kaunched new Integrated Tr...Read more
Daiichi develops antibody to prevent fracture
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Oct, 2012
Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...Read more
Gilead to halt phase III study of leukemia drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2013
Singapore: Gilead Sciences plans to halt phase III study evaluating idelalisib in previously-treated chronic lymphocytic...Read more
Sihuan, NeuroVive to develop heart and brain products
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Nov, 2012
Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two in...Read more
Bioxyne to report COPD trial results in June
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2012
Singapore: Australian company Bioxyne closed its 320-patient study, which was designed to evaluate the efficacy and safe...Read more
MicuRx next gen antibiotic gets US patent
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 May, 2012
Singapore: MicuRx Pharmaceuticals, a privately-held biopharmaceutical company developing next-generation antibiotics, ha...Read more